TY - JOUR
T1 - Flunitrazepam
T2 - More than a date rape drug
AU - Rickert, Vaughn I.
AU - Wiemann, Constance M.
AU - Berenson, Abbey B.
N1 - Funding Information:
This study was funded in part by the Hogg Foundation for Mental Health (VIR). These data were presented in part at the Society for Pediatric Research , May 4, 1998, in New Orleans, Louisiana.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2000/2
Y1 - 2000/2
N2 - Study Objective: To evaluate the independent relationship between depressive symptoms, self-esteem, and drug resistance self-efficacy, and future intentions to use flunitrazepam. Design: Cross-sectional survey. Setting: Community-based family planning clinics. Participants: 865 sexually active women who self-identified as Caucasian, African-American, or Mexican American, denied using flunitrazepam in the last 12 months and reported intentions to use or not use this substance in the next 12 months. Interventions: None. Main Outcome Measure: An anonymous self-report measure assessed the patient's intentions to use flunitrazepam in the next 12 months; other lifetime drug use; and standardized measures of depression, self-esteem, and drug resistance self-efficacy. We hypothesized that future potential users of flunitrazepam would exhibit an increased number of depressive symptoms, lowered self-esteem, and limited drug resistance self-efficacy. Results: Of the 865 subjects, 16 (1.8%) reported using flunitrazepam in their lifetime but not in the last 12 months, and 46 (5.3%) were identified as potential users. Logistic regression analyses controlling for confounding factors found that potential to use flunitrazepam was significantly associated with limited drug resistance self-efficacy (adjusted odds ratio [AOR] = 9.3) and the presence of both severe depressive symptoms and lowered self-esteem (AOR = 3.2). Conclusions: These data suggest that young women with severe depressive symptoms and diminished self-esteem are at high risk for future flunitrazepam use and may use this drug to self-medicate psychological distress.
AB - Study Objective: To evaluate the independent relationship between depressive symptoms, self-esteem, and drug resistance self-efficacy, and future intentions to use flunitrazepam. Design: Cross-sectional survey. Setting: Community-based family planning clinics. Participants: 865 sexually active women who self-identified as Caucasian, African-American, or Mexican American, denied using flunitrazepam in the last 12 months and reported intentions to use or not use this substance in the next 12 months. Interventions: None. Main Outcome Measure: An anonymous self-report measure assessed the patient's intentions to use flunitrazepam in the next 12 months; other lifetime drug use; and standardized measures of depression, self-esteem, and drug resistance self-efficacy. We hypothesized that future potential users of flunitrazepam would exhibit an increased number of depressive symptoms, lowered self-esteem, and limited drug resistance self-efficacy. Results: Of the 865 subjects, 16 (1.8%) reported using flunitrazepam in their lifetime but not in the last 12 months, and 46 (5.3%) were identified as potential users. Logistic regression analyses controlling for confounding factors found that potential to use flunitrazepam was significantly associated with limited drug resistance self-efficacy (adjusted odds ratio [AOR] = 9.3) and the presence of both severe depressive symptoms and lowered self-esteem (AOR = 3.2). Conclusions: These data suggest that young women with severe depressive symptoms and diminished self-esteem are at high risk for future flunitrazepam use and may use this drug to self-medicate psychological distress.
KW - Depressive symptoms
KW - Drug resistance self-efficacy
KW - Flunitrazepam
KW - Self medication
UR - http://www.scopus.com/inward/record.url?scp=0033931489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033931489&partnerID=8YFLogxK
U2 - 10.1016/S1083-3188(99)00038-8
DO - 10.1016/S1083-3188(99)00038-8
M3 - Article
C2 - 10742673
AN - SCOPUS:0033931489
SN - 1083-3188
VL - 13
SP - 37
EP - 42
JO - Journal of Pediatric and Adolescent Gynecology
JF - Journal of Pediatric and Adolescent Gynecology
IS - 1
ER -